Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A Medical Research Council Trial

Journal of Clinical Oncology

Volumn 19, Issue 2, 2001, Pages 509-518

  Thomas, D ^a   Brada, M ^a   Stenning, S ^a   Lantos, P ^a   Ironside, J ^a   Moss, T ^a   Whaley, J ^a   Bleehen, N M ^a   Roberts, J T ^a   Senanayake, L F N ^a   Abram, W P ^a   Gullan, R ^a   Murrell, D S ^a   McIntosh, J ^a   Tobias, J ^a   Godlee, J N ^a   Guthrie, D ^a   Bradford, R ^a   Campbell, D ^a   Sarkar, T ^a   Watson, J V ^a   Lamont, A ^a   Stone, J ^a   Mantell, B ^a   Plowman, P N ^a   Hope Stone, H ^a   Hoskin, P ^a   Ritchie, D ^a   Pigott, K ^a   Hawkins, R ^a   Baillie Johnson, H ^a   Lindup, R ^a   Adab, F ^a   Hurman, D ^a   Gaze, M ^a   Collis, C ^a   Neave, F ^a   Thomas, G ^a   Robinson, A ^a   more..

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGE; AGED; ARTICLE; ASTROCYTOMA; BLOOD DYSCRASIA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROSURGERY; NEUROTOXICITY; PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME; VOMITING;

EID: 0035863293     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.2.509     Document Type: Article

References (31)

1. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
2. Combined modality therapy of operated astrocytomas grade III and IV: Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time - A prospective multicentre trial of the Scandinavian Glioblastoma Study Group
3. A Medical Research Council Trial of two radiotherapy doses in the treatment of grade 3 and 4 astrocytoma: The Medical Research Council Brain Tumour Working Party
4. An overview of published results of randomized studies of nitrosoureas in primary high grade malignant glioma
5. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery
6. Controlled study with BCNU versus CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme
7. Combined modality treatment of operated astrocytomas grade 3 and 4: A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy - Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group
8. Adjuvant nitrosourea therapy for glioblastoma
9. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas
10. Effect of CCNU on survival rate of objective remission and duration
11. A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma
12. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
13. Meta-analysis of the literature or of individual patient data: Is there a difference?
14. Phase II study of procarbazine, CCNU and vincristine combination chemotherapy in the treatment of malignant brain tumors
15. Chemotherapy of malignant glioma with CCNU alone and CCNU combined with vincristine sulphate and procarbazine hydrochloride
16. Phase III comparison of BCNU and the combination of procarbazine, CCNU and vincristine administered after radiotherapy with hydroxyurea for malignant glioma
17. Comparisons of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma
18. Sensitivity of intracranial gliomas to vincristine sulphate
19. Modified procarbazine: CCNU and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors
20. Grading of astrocytomas: A simple and reproducible method
21. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: Accelerated radiotherapy in high-grade glioma
22. Superiority of postradiation adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for malignant glioma: NCOG 6G61 final report
23. Controlled study of CCNU and radiation therapy in malignant astrocytoma
24. Radiotherapy and CCNU: In the treatment of high-grade supratentorial astrocytomas
25. Evaluation of CCNU, VM-26 plus CCNU and procarbazine in supratentorial brain gliomas
26. Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas
27. Effects of ACNU and radiotherapy on malignant glioma
28. Post-operative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas
29. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas
30. Practical methodology of meta-analyses (overviews) using individual patient data: Cochrane Working Group